New York – BlueStone Managing Director, Mara Aspinall, in conjunction with other contributors, collaborated with the Rockefeller Foundation, to help launch its second National Covid-19 Testing & Tracing Action Plan.
The plan offers four sets of recommendations, including a national strategy for scaling up the use of Covid-19 screening tests for asymptomatic Americans, the plan requires at least $75 billion be made available for testing. It also calls on the U.S. Centers for Disease Control and Prevention (CDC) to lead in developing screening test protocols so organizations know how to protect against outbreaks and keep the economy functioning.
“This is not testing to count numbers. It is testing to stop transmission,” said Mara G. Aspinall, co-Founder and Professor of Practice, Biomedical Diagnostics at Arizona State University’s College of Health Solutions. “We need a paradigm shift from exquisitely accurate but slow tests, to fast and good enough to quarantine. Slow and accurate works for clinical management, but this virus is a sprinter not a marathoner. We need fast and frequent tests just to keep up.” READ MORE